-
Mashup Score: 0FDA Approves RSV Drug for Children Up to 24 Months - 2 year(s) ago
AstraZeneca’s new drug, a monoclonal antibody, was given FDA approval after the Antimicrobial Drugs Advisory Committee (AMDAC) to the FDA voted in June to recommend the approval of nirsevimab (Beyfortus) for the prevention of respiratory syncytial virus (RSV) disease in infants.
Source: Infection Control TodayCategories: Infectious Disease, Latest HeadlinesTweet
-
Mashup Score: 0
In his analysis, Kevin Kavanagh, MD, explores the measures taken by the infectious disease sector in response to the pandemic, pointing out both effective and ineffective approaches. He also discusses how the pandemic has affected the treatment of other infectious diseases.
Source: Infection Control TodayCategories: Infectious Disease, Latest HeadlinesTweet-
In his analysis, Kevin Kavanagh, MD, discusses how the pandemic has affected the treatment of other infectious diseases. https://t.co/q2P9PRFQ0A #COVID_19 #MRSA #Syphyilis #long_COVID
-
-
Mashup Score: 0
Dengue Fever and Betacoronavirus infections are widespread and dangerous. The cofounder and CEO of Emergex answers questions about them and upcoming Phase II and Phase III studies.
Source: Infection Control TodayCategories: Infectious Disease, Latest HeadlinesTweet-
Need information on Dengue Fever and Betacoronavirus? ICT asked Emergex's CEO for updates on Phase II and III studies. https://t.co/PmQefBpFYV @EmergexVaccines #dengue #MERS #SARS_CoV_2 #mosquitoborne #RNA
-
-
Mashup Score: 0Escherichia coli (E coli): What IPC Professionals Should Know - 2 year(s) ago
Have foodborne infections returned to prepandemic levels? What information should infection prevention and control personnel offer to patients and staff to prevent an E coli infection?
Source: Infection Control TodayCategories: Infectious Disease, Latest HeadlinesTweet-
Have foodborne infections returned to prepandemic levels? What information should infection prevention and control personnel offer to patients and staff to prevent an E coli infection? https://t.co/NzV1ciOEpm @epocrates #e_coli @CDCgov #shiga #Uti_prevention
-
-
Mashup Score: 2
Dengue Fever and Betacoronavirus infections are widespread and dangerous. The cofounder and CEO of Emergex answers questions about them and upcoming Phase II and Phase III studies.
Source: Infection Control TodayCategories: Infectious Disease, Latest HeadlinesTweet-
Dengue Fever and Betacoronavirus infections are widespread and dangerous. The cofounder and CEO of Emergex answers questions about them and upcoming Phase II and Phase III studies. https://t.co/NsO8ffBPOJ @EmergexVaccines #dengue #MERS #SARS_CoV_2 #mosquitoborne #RNA
-
-
Mashup Score: 0Escherichia coli (E coli): What IPC Professionals Should Know - 2 year(s) ago
Have foodborne infections returned to prepandemic levels? What information should infection prevention and control personnel offer to patients and staff to prevent an E coli infection?
Source: Infection Control TodayCategories: Infectious Disease, Latest HeadlinesTweet-
Escherichia coli (E coli): What IPC Professionals Should Know https://t.co/WXFY5ETJYU #e_coli @CDCgov #shiga #Uti_prevention
-
-
Mashup Score: 0Incorporating Horizontal Plasmid Transfer Findings in Bacterial Infection Prevention and Control - 2 year(s) ago
Alexander Sundermann, DrPH, CIC, FAPIC, discusses his work focused on whole genome sequencing surveillance for outbreak detection and investigation in healthcare settings.
Source: Infection Control TodayCategories: Infectious Disease, Latest HeadlinesTweet-
Alexander Sundermann, DrPH, CIC, FAPIC, is using whole genome sequencing to track outbreaks in health care facilities. Listen to the interview to hear more. https://t.co/qLrWXoV2ND #HAI #apic2023 @Apic2023 @PittTweet
-
-
Mashup Score: 0Pharmacists and Infection Preventionists: Collaboration on Antimicrobial Stewardship - 2 year(s) ago
A presentation at the APIC 2023 annual conference was about reducing the unnecessary treatment of asymptomatic bacteria, and the presenters shared some of the successful strategies they have implemented at their hospital.
Source: Infection Control TodayCategories: Infectious Disease, Latest HeadlinesTweet-
#AMR @APIC @Apic2023 @JPS_Health Presenters at the APIC conference discussed reducing the unnecessary treatment of asymptomatic bacteria. https://t.co/9vvTdwJAm9 #antimicrobial stewardship @apic @apic2023 @jps_health_network
-
-
Mashup Score: 0AORN Receives Award for Diversity, Equity, and Inclusion Efforts - 2 year(s) ago
Association of periOperative Registered Nurses received recognition from the Denver Business Journal for its efforts in promoting diversity and inclusion within its program that aims to improve nurses’ ability to address health disparities among underserved patient populations.
Source: Infection Control TodayCategories: Infectious Disease, Latest HeadlinesTweet-
AORN's program aims to improve nurses’ ability to address health disparities among underserved patient populations. https://t.co/LV5C5mAwhb @AORN #Denver_Business_Journal #DEI
-
-
Mashup Score: 1
Central line-associated bloodstream infection (CLABSI) can cause harm to patients or even lead to fatalities, while also resulting in additional expenses for hospitals.
Source: Infection Control TodayCategories: Infectious Disease, Latest HeadlinesTweet-
CLABSI can be detrimental to patients and can even result in fatalities, in addition to causing increased expenses for hospitals. https://t.co/DvTO9r7e0n #APIC2023 #CAUTI #Children
-
AstraZeneca's new drug, a monoclonal antibody, was given FDA approval after the Antimicrobial Drugs Advisory Committee (AMDAC) to the FDA voted in June to recommend the approval of nirsevimab (Beyfortus). https://t.co/aTUgS97M8F #RSV #astrazeneca